The Canadian company for views expands outside the recipes on demand for stigmatized conditions.
Digital Health Company from Toronto Felix It is expanding to offer constant health monitoring aimed at increasing “durability”, since Canadian patients are looking for options for preventive health care.
Felix is part of the growing list of Canadian startups of the TV form, which make convenience and discretion part of their draw
The new company longevity includes an annual test and current monitoring for $ 500 a year. The plan is offered by testing more than 35 biomarkers, including metabolic health indicators, the functioning of the kidneys and liver, testosterone, vitamins and measurements of inflammation. It also includes the “biological age” test, which is based on Levin phenotypic ageThe algorithm developed by the scientific researcher and former professor of Yale University Morgan Levin in 2018.
Emma Stern, co -founder and chief operating director of Felix, told Betakit in an interview with Betakit that testing notes “Departure from our traditional model” to provide consultations and recipes on demand. Founded in 2019, Felix sells therapy through a virtual platform, which covers grades, laboratory tests, prescriptions and drug delivery. He sells medicines and treatment for general conditions, such as erectile dysfunction, menopause, acne, hair loss, depression and anxiety, as well as contraceptives and medicines for the treatment of weight.
“There is this macro, where people see the value in preventive medical care and testing for longevity,” said Stern Betakit. “We saw a lot of demand for our user base.”
On the other hand, Stern claimed that Felix was aimed at the preventive health care market because the overloaded Canadian healthcare system was not served. More than Every fifth Canadians have no primary medical care doctor, and the study of the Canadian Medical Association of 2025 showed that 37 percent of Canadians were looking for Medical Council online Because they could not access healthcare.
“We felt that this was a very natural place for Felix to intervene,” Stern said.
In recent years, the science of anti -aging age has grown in the last years, partly thanks to the biohaking movement, which contributes to a change in lifestyle in order to optimize the functioning of the body and extend its life. A movement that stimulated many startups selling wellness plans, equipment and supplements also caused experiments with extreme life expansion experiments, such as a billionaire of Silicon Valley Brian Johnson, who is trying Turn the process of aging your bodyField
According to Stern and the director of Felix, Averrum Laurie, a program was developed to “overcome the noise” of existing misinformation and the hype around the medicine of longevity. The company said that the doctor Ontario Dr. Melody Hui helped to develop a program in order to ensure the clinical rule of its methods.
CONNECTED: Niahealt collects $ 5.75 million.
The longevity platform is available only in Ontario, British Colombia and Saskachevan. Home tests are available only in Ontario. After the tests, a licensed practitioner of any doctor, or a practitioner or practicing nurse, examines the results and creates a plan that may include “changes in lifestyle, medicine for the prescription and over-the-counter, prosperous additives”.
The toolbar allows patients to track their health over time and perform a chat function so that they can contact their doctor. More expensive, “Ultimate” level expanded biomarkers and video consultations.
Felix is part of the growing list of Canadian startups of the TV aid, such as Phoenix and Maple, which make the convenience and discretion of their draw for certain markets, especially for stigmatized conditions. While Felix is currently aiming at consumers directly, Stern said that the company continues to study other access capabilities.
The startup has raised more than 30 million dollars To nourish its expansion among investors, including the BDC Capital, the Canadian business growth fund and Whitecap Venture Partners.
Although Felix did not share his income, the company claims that its weight loss program is the most “in demand” and that it is observed at a 100 percent increase in patients from January to August this year. His weight treatment program includes GLP-1 agonist drugs, such as Ozempsik, which were originally developed for the treatment of diabetes, but also demonstrate the efficiency of weight loss.
Stern said that Felix sees an additional opportunity in this market as the patent of Novo Nordisk’s Outcups expires in early 2026, opening the door for pharmaceutical companies for Develop common versions of the drug And sell them at lower prices. She added that Felix “works in close cooperation” with drug manufacturers in order to ensure a permanent supply for its patients.
The image function is provided by UNSPLASH. Image by National Institute of CancerField
